Yoshimi. Miki, et.al., Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators., The Journal of experimental medicine, 2013, 210

http://rdf.ncbi.nlm.nih.gov/pubmed/23690440

Yoshimi. Miki, et.al., Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators., The Journal of experimental medicine, 2013, 210

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased dendritic cell number_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0008126B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• abnormal lipid homeostasis_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0002118B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• decreased interleukin-6 secretion_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0008706B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• abnormal effector T cell morphology_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0002435B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• decreased tumor necrosis factor secretion_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0008561B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• increased CD4-positive, alpha beta T cell number_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0008074B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• abnormal dendritic cell physiology_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0002376B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg
• increased susceptibility to type IV hypersensitivity reaction_Pla2g2d<tm1.1Mhg>/Pla2g2d<tm1.1Mhg>
  http://metadb.riken.jp/0005617B6NCrSlcCgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11MhgPla2g2dtm11Mhg